Kikuchi Norihiro, Shiozawa Toshihiro, Ishii Yukio, Satoh Hiroaki, Noguchi Masayuki, Ohtsuka Morio
Division of Respiratory Medicine, Institute of Clinical Medicine, University of Tsukuba.
Intern Med. 2007;46(8):491-4. doi: 10.2169/internalmedicine.46.6363. Epub 2007 Apr 17.
A 37-year-old man was referred to our hospital with complaints of dyspnea and general fatigue. Chest radiograph and CT scan revealed thickness of bronchovascular bundles in both lungs. In spite of various examinations, the primary lesion was not identified. He received chemotherapy containing TS-1 and cisplatin. Pulmonary lymphangitic carcinomatosis disappeared and the patient achieved a good partial response. He survived for 14 months after the chemotherapy. We believe the combination of TS-1 and cisplatin is one of the attractive options for patients with cancer of unknown primary site.
一名37岁男性因呼吸困难和全身乏力被转诊至我院。胸部X线片和CT扫描显示双肺支气管血管束增粗。尽管进行了各种检查，但原发病变仍未明确。他接受了含替吉奥（TS-1）和顺铂的化疗。肺淋巴管癌病消失，患者获得了良好的部分缓解。化疗后他存活了14个月。我们认为替吉奥和顺铂联合使用是不明原发部位癌症患者的有吸引力的选择之一。
